Correlation Between Hawkins and Cyclo Therapeutics

Can any of the company-specific risk be diversified away by investing in both Hawkins and Cyclo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hawkins and Cyclo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hawkins and Cyclo Therapeutics, you can compare the effects of market volatilities on Hawkins and Cyclo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hawkins with a short position of Cyclo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hawkins and Cyclo Therapeutics.

Diversification Opportunities for Hawkins and Cyclo Therapeutics

-0.29

Correlation Coefficient

Hawkins  Cyclo Therapeutics

Very good diversification

The 3 months correlation between Hawkins and Cyclo is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Hawkins and Cyclo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclo Therapeutics and Hawkins is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hawkins are associated (or correlated) with Cyclo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclo Therapeutics has no effect on the direction of Hawkins i.e., Hawkins and Cyclo Therapeutics go up and down completely randomly.

Pair Corralation between Hawkins and Cyclo Therapeutics

Given the investment horizon of 90 days Hawkins is expected to generate 10.58 times less return on investment than Cyclo Therapeutics. But when comparing it to its historical volatility, Hawkins is 7.63 times less risky than Cyclo Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Cyclo Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  13.00  in Cyclo Therapeutics on September 17, 2024 and sell it today you would lose (0.20) from holding Cyclo Therapeutics or give up 1.54% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Hawkins  vs.  Cyclo Therapeutics

Hawkins

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Hawkins are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting forward-looking signals, Hawkins may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Cyclo Therapeutics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cyclo Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain technical indicators, Cyclo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Hawkins and Cyclo Therapeutics

The main advantage of trading using opposite Hawkins and Cyclo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hawkins position performs unexpectedly, Cyclo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclo Therapeutics will offset losses from the drop in Cyclo Therapeutics' long position.

The idea behind Hawkins and Cyclo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.